GEM Interacting Protein Antibody
Novus Biologicals, part of Bio-Techne | Catalog # NBP2-84967
Key Product Details
Species Reactivity
Human
Applications
Western Blot
Label
Unconjugated
Antibody Source
Polyclonal Rabbit
Concentration
0.5 mg/ml
Product Specifications
Immunogen
The immunogen is a synthetic peptide directed towards the C-terminal region of Human GEM Interacting Protein. Peptide sequence: PGPDPQHHSTLEQHPTATPTEIPTPQSDQREDVAEDTKDGGGEVSSQGPE The peptide sequence for this immunogen was taken from within the described region.
Clonality
Polyclonal
Host
Rabbit
Scientific Data Images for GEM Interacting Protein Antibody
Western Blot: GEM Interacting Protein Antibody [NBP2-84967]
Western Blot: GEM Interacting Protein Antibody [NBP2-84967] - Host: Rabbit. Target Name: GMIP. Sample Type: Human 721_B. Antibody Dilution: 1.0ug/mlGMIP is supported by BioGPS gene expression data to be expressed in 721_BWestern Blot: GEM Interacting Protein Antibody [NBP2-84967]
Western Blot: GEM Interacting Protein Antibody [NBP2-84967] - WB Suggested Anti-GMIP Antibody. Titration: 1.0 ug/ml. Positive Control: COLO205 Whole CellApplications for GEM Interacting Protein Antibody
Application
Recommended Usage
Western Blot
1.0 ug/ml
Formulation, Preparation, and Storage
Purification
Affinity purified
Formulation
PBS, 2% Sucrose
Preservative
0.09% Sodium Azide
Concentration
0.5 mg/ml
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
Background: GEM Interacting Protein
Alternate Names
ARHGAP46, GEM-Interacting Protein
Gene Symbol
GMIP
Additional GEM Interacting Protein Products
Product Documents for GEM Interacting Protein Antibody
Product Specific Notices for GEM Interacting Protein Antibody
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...